Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6417565 | 0.74 | MEN1 (0.41) | — | |
| SCHEMBL7168721 | 0.73 | ACHE (0.33) | — | |
| SCHEMBL3266280 | 0.72 | — | — | |
| SCHEMBL992012 | 0.70 | — | — | |
| SCHEMBL18705410 | 0.69 | ALDH1A1 (0.43) | TSHR | |
| SCHEMBL22801230 | 0.68 | DNM1 (0.34) | — | |
| SCHEMBL2293466 | 0.67 | CSNK1E (0.46) | — | |
| SCHEMBL7457089 | 0.64 | — | — | |
| SCHEMBL7719561 | 0.63 | TSHR (0.30) | TSHR | |
| SCHEMBL30835196 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110135713-A1 | Antimicrobial and Antiviral Compounds and Methods for Their Use | LAKEWOOD-AMEDEX, INC. (US) | 2011-06-09 | — | — | US | disclosed |
| US-7868162-B2 | Antimicrobial and antiviral compounds and methods for their use | LAKEWOOD-AMEDEX, INC. (US) | 2011-01-11 | — | — | US | disclosed |
| US-20070053971-A1 | Antimicrobial and Antiviral Compounds and Methods for their Use | OLIGOS ETC., INC | 2007-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110135713-A1 | Antimicrobial and Antiviral Compounds and Methods for Their Use | MAVS, ITPA, STING1 | TSHR 4499/4885 |
| US-20070053971-A1 | Antimicrobial and Antiviral Compounds and Methods for their Use | MAVS, ITPA, STING1 | TSHR 4499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.